Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by AGT3, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. De plus, nous expédions Angiotensin III Anticorps (28) et et beaucoup plus de produits pour cette protéine.
Showing 9 out of 25 products:
Human Angiotensin III Kit ELISA pour Competition ELISA - ABIN415232
Anand, Yiangou, Sinisi, Fox, MacQuillan, Quick, Korchev, Bountra, McCarthy, Anand: Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. dans Molecular pain 2015
Show all 2 Pubmed References
Unfavorable genotype of polymorphic variants of candidate gene participating in endothelial dysfunction AGT (Montrer AGXT Kits ELISA) (Thrl74Met and Met23SThr) was associated with changes in levels of their active substances in individuals exposed to mercury.
These findings reveal the critical role of hypoxia in producing local angiotensin II by a lactate-chymase (Montrer CMA1 Kits ELISA)-dependent mechanism and highlight the importance of local angiotensin II in regulating radioresistance of hypoxic tumor cells.
The reduced urinary AGT (Montrer AGXT Kits ELISA)/creatinine in Autralian Indigenous pregnant women may reflect subclinical renal dysfunction which limits the ability of the kidney to maintain sodium balance and could indicate an increased risk of pregnancy complications and/or future renal disease.
ACE2 (Montrer ACE2 Kits ELISA) and other enzymes can form ANG-(1 (Montrer ANGPT1 Kits ELISA)-7) directly or indirectly from either the decapeptide ANG I (Montrer AGT Kits ELISA) or from ANG II (Montrer AGT Kits ELISA). [review]
The ACE (Montrer ACE Kits ELISA) and AGT (Montrer AGXT Kits ELISA) gene polymorphisms are not associated with the progress of diabetes developing into retinopathy in Chinese patients with type 2 diabetes.
AGT (Montrer AGXT Kits ELISA) M235T and T174M variants contribute to an increased risk of developing preeclampsia (PE), and for M235T to PE severity.
Data, including data using network analysis, suggest that angiotensinogen (AGT (Montrer AGT Kits ELISA)), mitogen-activated protein kinase-14 (MAPK14 (Montrer MAPK14 Kits ELISA)), and prothrombin (Montrer F2 Kits ELISA) (F2) in placental villous tissues are core factors in early embryonic development; these studies involved proteomics and bioinformatics analysis of altered protein expression in placental villous tissue from early recurrent miscarriage patients in comparison to control tissues.
The AGT (Montrer AGXT Kits ELISA) (M235T) gene polymorphism do not seem to have a significant effect on the development of clinical properties or cardiovascular comordities of acromegalic patients.
Angiotensin II has a role in increasing glomerular permeability by beta-arrestin mediated nephrin (Montrer NPHS1 Kits ELISA) endocytosis
After donor nephrectomy, increasing uAGT (Montrer DPAGT1 Kits ELISA) levels can be the result of activation of the intrarenal renin (Montrer REN Kits ELISA)-angiotensin system affecting the compensatory changes in the remaining kidney.
The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.
alpha-1 antiproteinase, antitrypsin
, angiotensin I
, angiotensin II
, serine (or cysteine) proteinase inhibitor
, serpin A8
, angiotensinogen (PAT)